Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2012

View Archived Issues

Kyowa Hakko Kirin withdraws Japanese submission for Nesp

Tyrosine-protein kinase SYK inhibitors may counter retinoblastoma

Roche prepares new HCV NS5B inhibitors

Researchers at Gilead Sciences prepare novel sodium channel blockers

Gilead Sciences discloses new agents for HIV infection

Novel DNA-dependent protein kinase inhibitors claimed by Merck KGaA

Korean scientists prepare novel compounds with muscle relaxant activity

New treatment for rosacea designed by Galderma Pharma

Marker of multiple sclerosis duration identified in cerebrospinal fluid

Study identifies markers of treatment response in ovarian cancer

NanoViricides submits pre-IND briefing document to FDA for FluCide

Ampion demonstrates improvement in pain relief in osteoarthritis

AcelRx Pharmaceuticals gives update on ARX-01

FDA accepts NPS Pharmaceuticals' NDA for teduglutide

Spectrum Pharmaceuticals in-licenses long-acting granulocyte colony-stimulating factor

TGen and University of Arizona receive funding for cancer research

Astellas and UCB sign Japanese development and commercialization agreement for Cimzia

Janssen seeks approval for Velcade subcutaneous injection in Japan

Juventas Therapeutics reports 1-year data for JVS-100

Pfizer recaps progress of 2011

Starpharma's dendrimer-docetaxel formulation shows superiority to docetaxel in breast cancer model

FDA approves ivacaftor for rare form of cystic fibrosis

TiGenix's study of Cx-611 in rheumatoid arthritis cleared to open final cohort

Mesoblast receives FDA clearance to conduct stem cell therapy study in diabetes

NIH joins phase II tuberculosis vaccine trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...